Türelmedet kérjük, amíg betöltjük a grafikon adatokat
AbbVie Inc közösség
About AbbVie Inc
What is AbbVie Inc?
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
AbbVie Inc Élő árfolyamadatok
The current price of AbbVie Inc in the market is 77 214,49 Ft, with a 24-hour trading volume of 505,57B Ft. The asset's market cap is 136,4T Ft, after moving -1.12% in the last day.
Tokenized AbbVie Inc is trading at 78 091,33 Ft, with a tokenized market cap of 265,51M Ft and a 24-hour trading volume of 61,83M Ft. The tokenized asset has moved 0.11% in the past 24 hours.